6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine
C23H25N9O — CID 142796692
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine
6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine (PubChem CID 142796692) has the molecular formula C23H25N9O and a molecular weight of 443.52 g/mol. Its IUPAC name is 6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | 6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 142796692 |
| Molecular Formula | C23H25N9O |
| Molecular Weight | 443.52 g/mol |
| Exact Mass | 443.22 |
| IUPAC Name | 6-(6-aminopyrazin-2-yl)-2-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine |
| SMILES | Nc1cncc(-c2cn3cc(-c4ccc(N5CCN(C6COC6)CC5)cc4)nc3c(N)n2)n1 |
| InChI | InChI=1S/C23H25N9O/c24-21-10-26-9-18(27-21)20-12-32-11-19(29-23(32)22(25)28-20)15-1-3-16(4-2-15)30-5-7-31(8-6-30)17-13-33-14-17/h1-4,9-12,17H,5-8,13-14H2,(H2,24,27)(H2,25,28) |
| InChIKey | CLHMYNWTDWKAFY-UHFFFAOYSA-N |
| XLogP | 1.54 |
| TPSA | 123.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.52 |
| LogP ≤ 5 | 1.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142796692 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.